Objectives: To assess the optimal setting of the predictive low glucose management (PLGM) algorithm for preventing exercise-induced hypoglycemia in adolescents with type 1 diabetes.
| INTRODUCTION
Regular exercise helps youth with diabetes to reduce hemoglobin A1c (HbA1c) 1 and cardiovascular risk, 2 and is therefore recommended as part of the therapeutic regimen. However, many barriers to exercise can exist for a person with diabetes, including fear of hypoglycemia, loss of glycemic control, and inadequate knowledge around exercise management. 3 In order to prevent hypoglycemia a tailored insulin regimen is recommended before and after physical activity with subjects using insulin pumps usually disconnecting from the pump or use a temporary lower basal rate before starting exercise. 4 Summer camp is considered as one of the best experiences for an adolescent with diabetes to learn self-confidence, independence, and the impact of exercise on diabetes management. It has been suggested that insulin doses should be reduced substantially during summer camps, especially in children not accustomed to physical activity. 5 Moreover, 60% of children reported an episode of hypoglycemia during the first day of a summer camp. 6 The introduction of new technologies may support adolescents in daily activities involving exercise. The predictive low glucose management, implemented in the SmartGuard features of the Medtronic Minimed 640G insulin pump, automatically suspends insulin delivery on a predicted hypoglycemia and resumes automatically based on recovery of glucose levels thus avoiding the occurrence of hypoglycemic events without significant hyperglicemia. 7 So far little information regarding the setting of low glucose suspend threshold under free-living condition is available.
In this study, we compare two different thresholds of glucose suspend setting during a 3-day summer camp in adolescents with type 1 diabetes.
| METHODS

| Subjects and enrolment
The study was conducted on 34 adolescents participating in a 3-day summer camp during 2016. Inclusion criteria were age between 15 and 20 years, diagnosis of type 1 diabetes of at least 12 months, using MiniMed 640G (Medtronic, Northridge, California) for ≥3 months, HbA1c <10%. Exclusion criteria were severe hypoglycemia or diabetic ketoacidosis (DKA) during 2 months before the enrolment, any medication or condition influencing metabolic control.
Subjects were recruited from 12 Centers of 10 Italian regions (Piedmont, Lombardy, Liguria, Lazio, Tuscany, Marche, Abruzzo, Puglia, Sicily, and Sardinia). All of the teenagers participating in the camp were using a MiniMed 640G, with different PLGM thresholds as instructed by their local physicians. 8 Physicians and teenagers were informed that during the camp, the medical staff might request the participant to modify their PLGM thresholds. The local Research Ethical Committee approved the study.
| Technology
The system consists of a Minimed 640G pump, Contour Next Link 2.4
wireless blood glucose meter (Ascensia, Milano, Italy), Enlite glucose sensor (Medtronic MiniMed, Northridge, California) and a Guardian 2 Link transmitter. The transmitter transmits the sensor glucose data wirelessly every 5 minutes to the pump providing real-time glucose measurements and trends. Calibration is required at least once every 12 hours. The pump is uploaded to transfer information to Medtronic
CareLink software through the use of the dedicated glucometer, which is also the uploading device. The pump is equipped with the PLGM function that suspends the insulin infusion 30 minutes in advance when the glucose levels are predicted to reach a pre-settled threshold.
| Study procedures
The study was an observational study of adolescents during physical activity with different PLGM thresholds in a protected, supervised camp setting.
Four weeks prior to the camp, the participants were trained and their ability to use the PLGM function was locally verified. At this stage, detailed information on study procedures were discussed with all participants, All participants PLGM threshold was 90 mg/dL from 11:00 PM to 8:00 AM (night-time), and 70 mg/dL from 8:00 AM to 11:00 PM (day-time).
At the camp, the participants were randomized into two groups: a group with PLGM threshold set at 90 mg/dL at the exercise starting and reset at 70 mg/dL after the exercise was finished (group A); the other group always maintained PLGM threshold at 70 mg/dL before, during and after exercise (group B). The threshold settings were verified by the staff members. Daily insulin doses, boluses, pump suspension time, glucose sensor data, and meter self-monitoring BG measurements were downloaded using Medtronic CareLink Personal software at the end of the camp.
| Study outcomes
The primary endpoint of the study was the time spent with BG levels below 70 mg/dL. Additional secondary outcomes included time spent with glycemia below 54 mg/dL, with BG levels between 70 to 180 mg/dL, over 180 mg/dL, and over 250 mg/dL.
| Statistical analysis
Baseline demographic characteristics and clinical data have been evaluated both for the whole sample and according to the PLGM thresholds groups. Quantitative variables were summarized as median and interquartile range (IQR, 1st; 3rd quartiles) and qualitative variables were expressed as absolute and percentage frequencies.
Time spent in hypoglycemia, at target, and in hyperglycemia was expressed as percentage of the total 3-day camp.
The variation in the BG levels were evaluated by measuring the total area under the curve (AUC) for each subject using the trapezoid method and was evaluated for the following time slots of three con- All the statistical analyses were performed using the R version 3.2.4. A level of probability lower than 5% was used to assess the statistical significance.
| RESULTS
Thirty-one adolescents completed the study. Two subjects did not have monitoring data and one had too many missing data (more than 30% of the total time), therefore they were excluded from the analysis.
Group A consisted of 18 adolescents with PLGM threshold at 90 mg/dL during exercise and Group B consisted of 13 participants with the PLGM threshold set at 70 mg/dL during exercise. The two groups were statistically similar ( Table 1 ).
The median age of the participants was 14. (Table 1 ). During the 6 months before the study, two episodes of severe hypoglycemia occurred in group B and no DKA events were reported.
No significant differences between groups were found in glycemic metrics (Table 2 ). In particular, the percentage of time-in-range was high in both during days and nights, whereas both time-belowrange and time-above-range were limited. Moreover, in both groups subjects were characterized by a good median level of glycemic variability during the 3-day period with 65.1% (53.7; 72.6) daytime time in range (70-180 mg%) and 69% (53.6; 80) night-time time in range (70-180 mg%). The median three nights glucose levels were additionally excellent, as reported by Rodbard. 9 No significant difference between the two groups was found in term of insulin suspension. In particular, in both groups, the insulin suspension occurred in about 70% after the first hour of mountain walking and more than 80% 6 hours after swimming or gym. The median trends were rather overlapping and no significant differences were found between the two groups in terms of AUCs.
Considering all participants together, we observed that PLGM automatically suspended insulin infusion 12 times, in average, during the camp-period, with a median of 4-times/day, each one for about 56 minutes.
| DISCUSSION
This short observational study of adolescents with type 1 diabetes using PLGM during moderate/intensive non-competitive physical activity demonstrated that automated insulin delivery systems with predictive algorithms that shut down basal insulin infusion, can provide safe insulin therapy with limited time spent in hypoglycemia and hyperglycemia, measured by sensor glucose.
The PLGM cut-off threshold at 90 mg/dL during exercise could be an advantage to prevent rapidly decreasing glucose values. However, it did not produce a significant improvement in reducing the Thus, a PLGM threshold at 70 mg/dL seems to be a good choice to keep BG within the euglycemic range with other glucose metrics, including median and glucose variability, as good even when adolescents practice aerobic and mixed physical activity in free-living conditions. Moreover, choosing a higher glucose threshold, a rebound hyperglycemia could affect glucose control, as shown in other studies, 11 but not in our study, although more pump suspensions were observed than in other studies. [12] [13] [14] However, it is noteworthy that during this camp, adolescents did not practice high intensity physical activity; therefore, it is difficult to generalize our results to all types of physical activities. Nevertheless, the physical activity practiced during the camp could be comparable to normal daily activities of adolescents.
The overall of time spent in the target range, and hyperglycemia was comparable between the two groups and it can be considered as a good result in current clinical practice.
The average suspension period in all subjects was higher than the ones observed in our previous experience with PLGM in 2015 12 and in other studies. 13, 14 We can hypothesize that the increase in suspensions were triggered by the emphasis on programmed exercise performed during the present study and the relative high suspend thresholds utilized. This automatic suspension is particularly useful in adolescents with type 1 diabetes to reduce worries about hypoglycemia, and overcome barriers limiting physical activity at this age group (15) .
During the last 3 years, increase in the utilization of continuous glucose monitoring systems in several studies on hybrid close-loop system and artificial pancreas as well as sensor augmented/integrated pumps and multiple daily injections of insulin reported data on glucose metrics making possible a basic comparison. Table 3 shows glucose metrics of studies performed at home and in free-living conditions. It is interesting to note that time spent in hypoglycemia, time in range, and in hyperglycemia was comparable with the results of our study, although these studies are based on a longer time of evaluation and different treatment modalities.
Interestingly, the percentage of time spent with BG over 250 mg/ dL in the present study was around 5% and it was comparable to the results reported in studies evaluating the effectiveness of bionic pancreas. 11 The coefficient of variation of BG over the three-day period was low and comparable with the variability showed by the bionic pancreas in a 5-day experiment with 32 adolescents during a summer camp 11 and a close loop system used at home during a 12-week period in 25 children and adolescents. 10 These all show that the automatic predicted low glucose, insulin suspension feature was effective in reducing exercise related hypoglycemia without increasing severe (above 250 mg/dL) hyperglycemia. In our study, we confirmed these findings using both suspension thresholds (70 and 90 mg/dL). In the traditional insulin treatment with both multiple daily injections and insulin pump, without automated insulin suspension, physical activity is associated with a late hypoglycemic effect occurring during the following night. In the present study, the nocturnal hypoglycemia was low and the suspension duration during the day and the night time were comparable (15% and 16%, respectively).
This study has several limitations; first, the observation period was too short to analyze long period effects of physical activity and the difference of HbA1c between groups could not be evaluated. Glucose values were monitored with the same sensor, detecting the risk of an upcoming hypoglycemia and later used as signal to restart the insulin pump, but they were not continuously compared with blood samples. Moreover, because physical activity during the summer camp was not comparable with everyday life of adolescents, the glucose metrics estimated in this study may not be generalized to the target population in everyday life. The study was conducted in a supervised environment, which is not similar to the real life conditions. This study did only limited comparisons-70 and 90 mg/dL thresholds during the exercise period, and did not address the effectiveness of different nocturnal thresholds. These should be assessed in future studies.
In conclusion, glucose metrics observed in this study using PLGM system showed that it could be considered useful to prevent hypoglycemia without increasing hyperglycemia during physical exercise in adolescents with type 1 diabetes, using the suspension thresholds settled both at 70 and 90 mg/dL. Studies with longer period and different thresholds will help to gain insights to maximize the clinical benefit of this new technology. Moreover, observing that the threshold setting with 90 mg/dL during the night revealed slightly more (non-significant) hyperglycemic time > 180 mg/dL and less time in target, while threshold with 70 mg/dL shows more suspensions, a threshold set at a medium value (80 mg/dL) could be the reasonable. However a specific designed study will be needed to address this hypothesis.
